Drug Shortage Report for TARO-GLICLAZIDE MR

Last updated on 2025-12-05 History
Report ID 169507
Drug Identification Number 02439328
Brand name TARO-GLICLAZIDE MR
Common or Proper name GLICLAZIDE
Company Name SUN PHARMA CANADA INC
Market Status MARKETED
Active Ingredient(s) GLICLAZIDE
Strength(s) 60MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100
ATC code A10BB
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-12-07
Estimated end date 2026-02-27
Actual end date
Shortage status Actual shortage
Updated date 2025-12-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v66 2025-12-05 French Compare
v65 2025-12-05 English Compare
v64 2025-12-01 French Compare
v63 2025-12-01 English Compare
v62 2025-11-11 French Compare
v61 2025-11-11 English Compare
v60 2025-11-03 French Compare
v59 2025-11-03 English Compare
v58 2025-10-06 French Compare
v57 2025-10-06 English Compare
v56 2025-07-07 French Compare
v55 2025-07-07 English Compare
v54 2025-06-04 French Compare
v53 2025-06-04 English Compare
v52 2025-05-20 French Compare
v51 2025-05-20 English Compare
v50 2025-03-17 French Compare
v49 2025-03-17 English Compare
v48 2025-03-03 French Compare
v47 2025-03-03 English Compare

Showing 1 to 20 of 66